Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRathbone Regulatory News (RAT)

Share Price Information for Rathbone (RAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,726.00
Bid: 1,812.00
Ask: 1,644.00
Change: 42.00 (2.49%)
Spread: -168.00 (-9.272%)
Open: 1,710.00
High: 1,732.00
Low: 1,676.00
Prev. Close: 1,684.00
RAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Jul 2020 10:47

RNS Number : 2662S
Rathbone Brothers PLC
07 July 2020
 

Rathbone Brothers Plc (the "Company") 

Notification of Transactions of Persons Discharging Managerial Responsibilities

The Company announces that on 6 July 2020, ordinary shares of 5p were allotted at £14.60 (mid-market close on 3 July 2020) to Equiniti Share Plan Trustees Limited, the trustee of the Company's Inland Revenue Approved Share Incentive Plan in respect of partnership shares and matching shares.

 

Subject to the deed and rules of the plan, the shares will continue to be held on the behalf of the following PDMRs.

 

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Enquiries:

 

Ali Johnson

Company Secretary

Telephone - 07901 118456

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul Stockton

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rathbone Brothers Plc

b)

LEI

213800MBTHM6UE8ZQP29

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each

ISIN: GB0002148343

b)

Nature of the transaction

Acquisition of partnership and matching shares under the Rathbone Brothers Plc Inland Revenue Approved Share Incentive Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£14.60

 10 partnership shares

£14.60

 10 matching shares

d)

Aggregated information 

 

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

2020-07-06

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Sarah Owen-Jones

2

Reason for the notification

a)

Position/status

Chief Risk Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rathbone Brothers Plc

b)

LEI

213800MBTHM6UE8ZQP29

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each

ISIN: GB0002148343

b)

Nature of the transaction

Acquisition of partnership and matching shares under the Rathbone Brothers Plc Inland Revenue Approved Share Incentive Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£14.60

 10 partnership shares

£14.60

 10 matching shares

d)

Aggregated information 

 

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

2020-07-06

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mike Webb

2

Reason for the notification

a)

Position/status

CEO of RUTM and Head of Marketing

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rathbone Brothers Plc

b)

LEI

213800MBTHM6UE8ZQP29

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p each

ISIN: GB0002148343

b)

Nature of the transaction

Acquisition of partnership and matching shares under the Rathbone Brothers Plc Inland Revenue Approved Share Incentive Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£14.60

 11 partnership shares

£14.60

 11 matching shares

d)

Aggregated information 

 

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

2020-07-06

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSISUWESSELW
Date   Source Headline
2nd Oct 20232:28 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
2nd Oct 202310:39 amRNSTotal Voting Rights
29th Sep 20233:04 pmGNWForm 8.3 - Renewi PLC
29th Sep 20232:59 pmGNWForm 8.3 - Instem PLC
29th Sep 20232:56 pmGNWForm 8.3 - Ergomed PLC
29th Sep 20232:51 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
29th Sep 20237:00 amRNSDirectorate Change
28th Sep 20231:09 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
27th Sep 20231:50 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
27th Sep 20231:48 pmGNWForm 8.3 - Finsbury Food Group PLC
26th Sep 20232:28 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
26th Sep 20232:24 pmGNWForm 8.3 - Finsbury Food Group PLC
26th Sep 20232:21 pmRNSHolding(s) in Company
25th Sep 20233:50 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
25th Sep 20233:42 pmGNWForm 8.3 - Finsbury Food Group PLC
25th Sep 20233:34 pmGNWCorrection: Form 8.3 - Dechra Pharmaceuticals PLC
22nd Sep 20232:08 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
22nd Sep 20231:17 pmRNSHolding(s) in Company
21st Sep 202312:19 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
21st Sep 20238:04 amRNSCompletion of the Combination
20th Sep 20233:24 pmRNSUpdate on the Combination with Investec W&I UK
20th Sep 20239:38 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
19th Sep 202310:31 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
18th Sep 20232:41 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Sep 20233:24 pmRNSHolding(s) in Company
15th Sep 20232:07 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
14th Sep 20231:31 pmGNWForm 8.3 - Instem PLC
14th Sep 20231:29 pmGNWForm 8.3 - Ergomed PLC
14th Sep 20231:26 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Sep 202311:16 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
11th Sep 20231:45 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
8th Sep 202310:56 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
8th Sep 202310:53 amGNWForm 8.3 - [Insert name of offeree or offeror]
7th Sep 20231:20 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
6th Sep 20237:00 amRNSDeclaration of Second Interim Dividend
5th Sep 20233:19 pmRNSDirector/PDMR Shareholding
5th Sep 202311:51 amGNWForm 8.3 - ERGOMED PLC
5th Sep 202310:19 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
4th Sep 202312:22 pmGNWForm 8.3 - [Insert name of offeree or offeror]
1st Sep 20232:19 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
1st Sep 20232:15 pmGNWForm 8.3 - Instem PLC
1st Sep 20239:21 amRNSTotal Voting Rights
31st Aug 202310:29 amGNWForm 8.3 - Instem PLC
31st Aug 202310:24 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
30th Aug 20233:33 pmRNSDirector/PDMR Shareholding
30th Aug 202310:06 amGNWForm 8.3 - [Insert name of offeree or offeror]
29th Aug 202310:48 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
29th Aug 20238:51 amRNSDirector/PDMR Shareholding
25th Aug 202310:12 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
24th Aug 20232:16 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.